CRISPR Therapeutics AG

CRISPR Therapeutics AG

CRSP

Market Cap$3.13B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
CRISPR Therapeutics AGCRISPR Therapeutics AG-8.1--21%-0.1
$-3.57

Current Fair Value

109.4% downside

Overvalued by 109.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$3.13 Billion
Enterprise Value$3.12 Billion
Dividend Yield$0 (0%)
Earnings per Share$-4.34
Beta1.87
Outstanding Shares85,938,720

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-8.09
PEG-48.59
Price to Sales-
Price to Book Ratio1.81
Enterprise Value to Revenue86.45
Enterprise Value to EBIT-6.52
Enterprise Value to Net Income-9
Total Debt to Enterprise0.07
Debt to Equity0.12

Revenue Sources

No data

Insider Trades

ESG Score

No data

About CRISPR Therapeutics AG

CEO: Samarth Kulkarni